MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, LGNZZ has $1,476,772K in assets. $526,601K in debts. $139,376K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2468.71%
Quick Ratio
2429.75%
Cash Ratio
456.39%
Debt to Asset Ratio
35.66%
Assets Breakdown
    • Short-term investments
    • Intangible assets, net
    • Long-term portion of financial r...
    • Others
Liabilities Breakdown
    • Retained earnings
    • Long-term portion of 2030 conver...
    • Additional paid-in capital
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
Cash and cash equivalents
139,376
Short-term investments
525,146
Accounts receivable, net
57,560
Inventory
11,900
Short-term portion of financial royalty assets, net
12,416
Income taxes receivable
536
Other current assets
6,986
Total current assets
753,920
Intangible assets, net
233,535
Goodwill
101,541
Long-term portion of financial royalty assets, net
206,332
Noncurrent derivative assets
9,351
Property and equipment, net
3,466
Lease right-of-use assets
7,609
Equity method investments
42,000
Other investments
106,721
Deferred income taxes, net
9,526
Other assets
2,771
Total assets
1,476,772
Accounts payable
3,679
Accrued liabilities
24,084
Income taxes payable
1,284
Current contingent liabilities
268
Current operating lease liabilities
1,089
Other current liabilities
135
Total current liabilities
30,539
Long-term deferred revenue
0
Long-term contingent liabilities
3,569
Long-term operating lease liabilities
4,415
Long-term portion of 2030 convertible senior notes, net
445,493
Deferred income taxes, net
22,673
Other long-term liabilities
19,912
Total liabilities
526,601
Common stock, 0.001 par value 60,000 shares authorized 19,656 and 19,106 shares issued and outstanding at september30, 2025 and december31, 2024, respectively
20
Additional paid-in capital
362,614
Accumulated other comprehensive income (loss)
9,322
Retained earnings
578,215
Total stockholders equity
950,171
Total liabilities and stockholders equity
1,476,772
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other current assets$6,986K Income taxesreceivable$536K Short-term portion offinancial royalty assets,...$12,416K Inventory$11,900K Accounts receivable, net$57,560K Short-term investments$525,146K Cash and cashequivalents$139,376K Other assets$2,771K Deferred income taxes,net$9,526K Other investments$106,721K Equity methodinvestments$42,000K Lease right-of-useassets$7,609K Property and equipment,net$3,466K Noncurrent derivativeassets$9,351K Long-term portion offinancial royalty assets,...$206,332K Goodwill$101,541K Intangible assets, net$233,535K Total current assets$753,920K Total assets$1,476,772K Total liabilities andstockholders equity$1,476,772K Total stockholdersequity$950,171K Total liabilities$526,601K Retained earnings$578,215K Accumulated othercomprehensive income (loss)$9,322K Additional paid-in capital$362,614K Common stock, 0.001 parvalue 60,000 shares...$20K Other long-termliabilities$19,912K Deferred income taxes,net$22,673K Long-term portion of 2030convertible senior notes,...$445,493K Long-term operating leaseliabilities$4,415K Long-term contingentliabilities$3,569K Total currentliabilities$30,539K Other currentliabilities$135K Current operating leaseliabilities$1,089K Current contingentliabilities$268K Income taxes payable$1,284K Accrued liabilities$24,084K Accounts payable$3,679K

LIGAND PHARMACEUTICALS INC (LGNZZ)

LIGAND PHARMACEUTICALS INC (LGNZZ)